The effect of prp on oligospermia
Not Applicable
Recruiting
- Conditions
- Oligostenoteratozoospermia.OligospermiaN46.1
- Registration Number
- IRCT20220317054318N4
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 160
Inclusion Criteria
Age range 20-45 years
Sperm count <20 million
Movement less than 106 x 5 ml, progressive movement < 20%, normal morphology < 10%
Not receiving other treatments such as hormone therapy
Not suffering from underlying diseases (such as diabetes, kidney disease, liver disease, drug and alcohol addiction) and types of cancer and receiving chemotherapy treatments
Absence of signs of infection in semen
Untreated varicocele
Exclusion Criteria
Unwillingness to continue participating in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sperm DNA fragmentation index. Timepoint: Before the start of the intervention and after 3 months from the time of PRP injection. Method of measurement: Sperm DNA breakage index test.
- Secondary Outcome Measures
Name Time Method